Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07179952 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )

StatusNot Yet Recruiting
PhasePhase 2
Started2027-01-01
View on ClinicalTrials.gov ↗

Amendment history

2026-02-25
Study Status v2
Start date2025-12-30→2027-01-01
2025-11-21
Study Identification, Study Status, Study Description, Arms and Interventions, Eligibility v1
Start date2025-10-01→2025-12-30
Eligibility criteria+223 characters
[...] eversibility if testing was performed under either the 2017 European Respiratory Society (ERS) technical standard (22) or the 1999 American Thoracis Society (ATS) Guidelines (23) or outside studies, provided that full sets [...] thacholine responsiveness: Positive methacholine defined as Provocative Concentration of Methacholine causing a 20% fall in FEV1 (PC20) ≤ 16 mg/ml, or Provocative Dose of Methacholine causing a 20% fall in FEV1 (PD20) ≤ 400 mcg Physician diagnosis of asthma according to NHLBI guidelines Consistent use of an Inhaled Corticosteroids (ICS) inhaler for the prior 2 months Non-smok [...] [...]
Study description+45 characters
[...] chodilator used for the test. Methacholine Challenge Testing (MCT): This test will be done only if the participant failed to demonstrate 10% reversibility in Forced Expiratory Volume in 1 Second (FEV1) and there are no historical MCT results available. MCT is d [...]
Study title+26 characters
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
2025-09-11
Original filing
Indiana University
306 trials monitored
See 37 trials at risk
Asthma
918 trials monitored
See 28 trials at risk
There is evidence to suggest that DHEA-based treatment could be beneficial to patients with asthma, yet one of the main treatments for asthma (taking glucocorticoids, a hormone that is effective in reducing inflammation), suppresses the production of DHEA. In this study, the investigators want to test and evaluate the safety of DHEA-based treatment.
Trial Details
NCT Number NCT07179952
Lead Sponsor Indiana University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Asthma
Enrollment 30 participants
Start Date 2027-01-01
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-27